Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Fish Forum Fish at the Podium

C5 2015 Pharma & Biotech Patent Litigation Conference

Thursday, March 19th, 2015

Fish Forum Fish at the Podium

C5 2015 Pharma & Biotech Patent Litigation Conference

Thursday, March 19th, 2015

Back to Events Listing

Fish Principal Martina Tyreus Hufnal and Douglas McCann, both of the Delaware office, will speak during the C5 2015 Pharma & Biotech Patent Litigation Conference, scheduled for March 19-20 in Amsterdam, Netherlands. Details are included below and also available on the conference website.

2015 Pharma & Biotech Patent Litigation Conference
19th – 20th March 2015 | Hotel Okura, Amsterdam, Netherlands

March 19th | 2:50pm
BioPharma Patents at the PTAB and the Implications on U.S. Litigation

Martina Tyreus Hufnal, Principal, Fish & Richardson (US)

• Broad overview of the IPR proceedings recently implemented by the U.S. Patent and Trademark Office
• Recent trends of the IPR proceedings on biotech and pharma patents
• How the IPR proceedings are impacting district court litigation
March 20th | 11:50am
New Frontiers for Patentable Subject Matters: Stem Cells, Gene Sequences, Plant Varieties. What Does This Mean for Your Patenting Strategy? Recent Case Law in EU and US and Issues of Legal Uncertainty

Rob. J. Aerts, Senior Patent Attorney, Keygene N. V. (Netherlands)
Douglas McCann, Principal, Fish & Richardson (US)

• Patentability of stem cells and embryos: what considerations should a pharmaceutical R&D business take into account?
• How the International Stem Cells Corp. case affects your R&D and patent strategy
• Broccoli, Tomatoes and essentially biological processes to produce plant varieties: what will change? Are plants obtained by a process excluded from patentability itself patentable?
• Is the patenting of stem cells and plants a matter of EU law or of EPC law? The current hybrid

Stay current with Fish Sign up for our Newsletter